| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | Chief Medical Officer | Common Stock | 1.38 M | $687 K | $0.50 | Jan 24, 2024 | Direct |
| Perspective Therapeutics, Inc. | Chief Medical Officer | Stock option (right to buy) | 150 K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Chief Medical Officer |
| CATX | Perspective Therapeutics, Inc. | Jan 24, 2024 | 1 | $140 K | 4 | Jan 26, 2024 | Chief Medical Officer |
| CATX | Perspective Therapeutics, Inc. | Dec 15, 2023 | 3 | $189 K | 4 | Dec 19, 2023 | Chief Medical Officer |
| CATX | Perspective Therapeutics, Inc. | Dec 12, 2023 | 1 | $0 | 4 | Dec 14, 2023 | Chief Medical Officer |
| CATX | Isoray, Inc. | Feb 3, 2023 | 0 | $0 | 3 | Feb 13, 2023 | Chief Medical Officer |